Winway Health Desk
Bristol Myers Squibb hematology chief talks COVID challenges, opportunities in blood cancer...
Bristol Myers Squibb’s hematology group began the year integrating acquired therapies from Celgene and prepping new therapies for debut, strategizing launches and looking at...
Johnson & Johnson’s immunology, cancer blockbusters deliver Q3 growth—and fuel hopes...
Some still see the doctor's office as a no-go zone as the coronavirus continues to circulate, and clinical trials have endured plenty of pandemic-related...
Startups to improve home health: Video from MedCity INVEST Digital Health
Healthcare entrepreneurs are an essential part of the innovation landscape and they play center stage at several of MedCity’s events. At MedCity INVEST Digital...
Takeda-led alliance starts scaling up production of COVID-19 plasma therapy as...
Another potential COVID-19 treatment has started late-stage testing, but in one respect it's different from the rest: It’s made by concentrating blood samples from...
HCD Virtual Session Q+A: The Spectrum of Technologies
HCD Virtual will be held Nov. 9-12 and offer a variety of keynote and breakout sessions delivered over four days. Healthcare Design is previewing...
Mexico targets a group of Indian generics makers for homeland pharma...
The human cost of the COVID-19 pandemic has been a strain on countries' ability to obtain medicines produced abroad with lockdowns shutting down inspections...
At HLTH, FDA chief reiterates that vaccine approvals will be evidence-based
In a virtual keynote address Monday at the HLTH conference, the head of the U.S. Food and Drug Administration renewed his vow that decisions...
AstraZeneca debuts cancer awareness campaign to encourage continuing care during COVID-19
AstraZeneca wants people to know that while many aspects of daily life have stopped during the pandemic, cancer hasn’t.
That's the goal of the company's “New...
Don’t miss our patient engagement conference ENGAGE at HLTH Oct 15
MedCity News has partnered with the premier healthcare conference, HLTH, to bring its patient engagement summit to the annual HLTH event. ENGAGE at HLTH will take...
FiercePharmaPolitics—Pfizer Vyndaqel copay lawsuit could bring drug pricing shockwaves
Welcome to the FiercePharma political roundup, where each Monday we’ll highlight developments in Washington, D.C., and elsewhere that could affect drug pricing and how drugmakers operate.
Pfizer’s fast-growing and costly heart...
